(Q68292551)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1671646%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

title

Plasma homovanillic acid and prognosis in schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1671646%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

Plasma homovanillic acid and prognosis in Schizophrenia (English)

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90048-Q

25 October 2022

1 reference

N. J. Baker

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671646

25 October 2022

D. G. Kirch

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671646

25 October 2022

M. Waldo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671646

25 October 2022

J. Bell

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671646

25 October 2022

L. E. Adler

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671646

25 October 2022

S. Hattox

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671646

25 October 2022

R. Murphy

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671646

25 October 2022

R. Freedman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671646

25 October 2022

language of work or name

English

0 references

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1671646%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

15 January 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1671646

full work available at URL

25 October 2022

https://api.elsevier.com/content/article/PII:000632239190048Q?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90048-Q

https://api.elsevier.com/content/article/PII:000632239190048Q?httpAccept=text/plain

25 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90048-Q

25 October 2022

published in

Biological Psychiatry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1671646%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1671646%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1671646%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

page(s)

192-196

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1671646%20AND%20SRC:MED&resulttype=core&format=json

Reproducibility of the measurement of plasma noradrenergic and dopaminergic metabolites in normal subjects

23 September 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90048-Q

Plasma catecholamine metabolites and treatment response at neuroleptic steady state

25 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90048-Q

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

25 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90048-Q

Plasma homovanillic acid levels and subtyping of schizophrenia

25 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90048-Q

Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons

25 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90048-Q

Plasma homovanillic acid as a predictor of response to neuroleptics

25 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90048-Q

Plasma homovanillic acid concentration and the severity of schizophrenic illness

25 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90048-Q

The effect of neuroleptic discontinuation on psychopathology, involuntary movements, and biochemical measures in patients with persistent tardive dyskinesia

25 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90048-Q

Plasma homovanillic acid and tardive dyskinesia during neuroleptic maintenance and withdrawal

25 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90048-Q

Plasma amine metabolites before and after withdrawal from neuroleptic treatment in chronic schizophrenic inpatients.

25 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90048-Q

Application and evaluation of limited mass monitoring with a gas chromatograph mass spectrometer computer system

25 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90048-Q

Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment

25 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90048-Q

25 October 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1671646%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference